DOCTOR SEARCH

Dr. Amanda LU serves as acting Chief of the Obstetrics and Gynecology Department at Jiahui Health. Dr. Lu has more than 20 years of clinical and teaching experience in Obstetrics and Gynecology. She specializes in comprehensive diagnosis and treatment of various types of uterine fibroids. She was in charge of establishing the Jiahui Gynecological Minimally Invasive Diagnosis and Treatment Center with level-4 laparoscopic surgery qualifications. In recent years, she has performed nearly 1,000 single-port laparoscopic and complex hysteroscopic surgeries at Jiahui.

She currently serves as:
Member of the Quality and Safety Committee of Shanghai Jiahui International Hospital
Member of the Obstetrics, Endocrinology, Metabolism and Nutrition Committee of the Shanghai Maternity and Infant Association
Member of the Gynecological Oncology Committee of the Shanghai Anti-Cancer Association

•Various gynecological hysteroscopic and laparoscopic minimally invasive surgeries, particularly single-port laparoscopy and ERAS (rapid recovery after surgery) technology;
•Prevention and comprehensive treatment of gynecological tumors;
•Diagnosis and treatment of cervical lesions, menstrual disorders, perimenopausal management and other reproductive endocrine problems;
•Possessing the GMAA (International Maternity and Childbirth Alliance) intermediate certificate in pelvic floor rehabilitation technology, qualification certificate in assisted reproductive technology, etc.

Dr. Lu graduated from Shanghai Jiao Tong University School of Medicine with a master’s degree of Obstetrics and Gynecology. She received her Medical Doctorate degree from Nanjing Medical University in 2016.

She has served as a instructor for resident doctors in Shanghai and a tutor for the medical PBL course. She has worked as a part-time physician in international hospitals and provided medical services for elites and international clients.

XU Shuguang, Ph.D., Deputy Chief Physician, Breast Surgery Department, Renji Hospital, Shanghai Jiaotong University School of Medicine;

Specialties:
Breast tumor, minimally invasive surgery, radical surgery, oncoplastic breast preservation surgery, Stage I breast reconstruction surgery, and the application of endoscopic technology in surgical treatment.

Personal Profile:
Dr. XU has been engaged in the diagnosis and treatment of breast diseases for more than 20 years, is the member of the breast cancer Professional Committee of Shanghai Anti-Cancer Association.
Dr.XU can provide patients with sophisticated minimally invasive rotary surgery, modified breast cancer surgery, oncoplastic breast preservation surgery that combines tumor treatment with optimal appearance, sentinel lymph node biopsy with minimal trauma, and breast reconstruction surgery.

Dr. ZHANG Hongwei, MD, is a consultant in Breast Institute at Jiahui Health. He served as the Chief Physician of General Surgery and the leader of breast cancer multidisciplinary team in Zhongshan Hospital, affiliated to Fudan University. Dr. ZHANG is the member of China AntiCancer Association Breast Society, the Vice Chairman of Shanghai AntiCancer Association Breast Society, and the Vice Chairman of Shanghai Association of Chinese Integrative Medecine Breast Society. He is also the Standing Committee member of Chinese Association for Research and Advancement of Chinese Medicine and the member of Chinese Medical Doctor Association Breast cancer Precision Therapy Committee.
Dr. ZHANG has been specialized in breast surgery for over 20 years, and he went for a visiting scholar in Barnes-Jewish Hospital, Washington University in St. Louis. He is specialized in the diagnosis and treatment of breast cancer including radical mastectomy, modified radical mastectomy, breast-conserving surgery, sentinel lymph node biopsy, immediate reconstruction after modified radical mastectomy and neoadjuvant chemotherapy. Dr. ZHANG developed standardized and individualized treatment plans for patients based on the medical evidence, which lead to the better long-term outcomes. 

Dr. HU Dingzhong is the specially-invited expert of thoracic surgery at Jiahui International Health. He serves as chief physician of thoracic surgery in the Shanghai Chest Hospital. Dr. Hu has been devoted to thoracic surgery clinical work for nearly 30 years, with an annual operation volume of more than 2,000 cases. He has accumulated rich clinical experience in thoracic surgery. Dr. Hu specializes in the diagnosis, differential diagnosis, and surgical treatment of chest benign and malignant diseases such as lung, esophagus, mediastinum, chest wall l, and trachea. He is especially skilled at complex surgical operations of thoracic surgery, including various high complex tracheal tumors, tracheal stenosis, and complex tumor surgical operations on the top of the chest, as as well as vena cava replacement in the treatment of thymic tumors. In the past 10 years, Dr. Hu has extensively carried out minimally invasive thoracic surgeries. He is skilled in all kinds of central complicated lung and mediastinal surgery under thoracoscope. He has performed the leading amount of thoracic robotic surgery cases in China. He also focuses on research for the surgical treatment of emphysema and lung transplantation for various end-stage lung diseases.

Dr. LI Jun is a Distinguished Surgical Expert at Shanghai Jiahui International Hospital and currently works at Beijing Tsinghua Changgung Hospital.

Dr. LI graduated at the Shanghai Medical University (now Fudan University), having the internship at Zhongshan Hospital and the Master degree at Cancer Hospital, Shanghai Medical University. He received the MD degree at the University of Essen in Germany and further the surgical training thereafter. He built his career in four prestigious European University Hospitals (Essen, London, Tübingen, Hamburg), with specialty of Surgery, General Surgery, Visceral Surgery, Hepato-Pancreatico-Biliary Surgery and Transplantation. Prior to Jiahui, he was in charge of Hepato-Pancreatico-Biliary Surgery at the University Medical Center Hamburg-Eppendorf, one of the five “Center of Excellence for Liver Surgery (DGAV)” in Germany.

Dr. LI has fundamental interesting in the surgical treatment of liver, biliary tract and pancreas disease. He made many surgical innovations. Some of them were published in the international prestigious journal. Applying the transplant technique and strategy on the treatment of cancers (as the part of transplant oncology) and performing minimal invasive surgery including robotic surgery (Da Vinci) are his current main focuses.

Dr. LI specializes in surgical techniques including but not limited to:
● Treatment of hepato-pancreatico-biliary malignancy, especially HCC, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinom, gall bladder cancer, pancreas cancer and complex resection and reconstruction, including surgical palliation.
● Treatment of benign diseases of liver, biliary tract and pancreas, such as gall stone disease, iatrogenic biliary injury, intrahepatic stone disease, cystic liver lesion, portal hypertension. Many surgeries could be performed laparoscopically. Large part of liver benign tumor may not require a surgery. Some patients with jaundice can be treated non-surgically.
● Treatment of peritoneal and retroperitoneal tumor, which requiring reconstruction of large or small vessels, biliary tract, intestinal and even ureter.
● Treatment of gastro-intestinal tumor, including gastric cancer, colorectal cancer, tumor of the small bowel, gastrointestinal stromal tumor.
● Lymph nodes biopsy and lymphadnectomy in the area of neck, axillar, groin, abdomen or pelvis.
● Varies of laparoscopic operation, including liver resection, distal pancreas resection, gastrointestinal resection and reconstruction, cholecystectomy and hernia repair.

Dr. LI has wide international connection and reputation. He is the member of German Surgical Society, German Transplant Society, European Society of Transplantation, International Society of Transplantation, European Hepato-Pancreatico-Biliary Association, International European Hepato-Pancreatico-Biliary Association.

License no. :沪卫外医批字（2023）第046号

Expertise
Surgical treatment of gastric cancer (open surgery, laparoscopic surgery, robotic-assisted surgery)
Minimally invasive surgery and comprehensive treatment with perioperative chemotherapy
Preservation and improvement of quality of life after gastrectomy

Introduction
Dr. Souya Nunobe is a specially invited expert at Jiahui Health and currently serves as the Deputy Director of the Hospital and Director of the Department of Gastric Surgery at the Cancer Institute Hospital in Japan.

Since 1996, Dr. Nunobe has been dedicated to the field of gastric cancer surgery. He completed his residency and specialized training at top Japanese institutions, including the University Hospital of Kyoto Prefectural University of Medicine and the National Cancer Center Hospital. He studied under renowned gastric cancer surgery experts, Professor Takeshi Sano and Professor Mitsuru Sasako, where he systematically acquired the core concepts and techniques of surgical oncology.

Starting in 2005, he actively promoted the application of minimally invasive surgery in gastric cancer treatment and introduced robotic-assisted surgery in 2019. Dr. Nunobe previously served as an Assistant Professor in Gastrointestinal Surgery at the Graduate School of Medicine, The University of Tokyo. He returned to the Department of Gastric Surgery at the Cancer Institute Hospital in 2010, became Vice Director of Gastric Surgery in 2016, was promoted to Director in 2019, and has additionally served as Deputy Director of the Hospital since 2023.

Dr. Nunobe has published over 160 peer-reviewed academic articles and serves on the editorial board of the Japanese Journal of Clinical Oncology. In 2007, he received the Nishi Memorial Award from the Japanese Gastric Cancer Association for his research on "quality of life after pylorus-preserving gastrectomy." Additionally, he has performed more than 20 live demonstrations of radical gastrectomy outside Japan, including in mainland China, Hong Kong, and Vietnam.

Dr. Nunobe also holds the following positions: Councilor of the Japanese Society of Gastroenterological Surgery, Councilor of the Japanese Gastric Cancer Association, Member of the Japanese Surgical Society, and Executive Member of the International Gastric Cancer Congress.

Expertise: Surgical and comprehensive treatment of head and neck tumors, including thyroid cancer, medullary thyroid carcinoma, parotid gland cancer, submandibular gland cancer, laryngeal cancer, etc.

Dr. SHI Rongliang is a multi-site practicing physician at Shanghai Jiahui International Hospital. He also serves as Associate Chief Physician and Associate Professor in the Department of Head and Neck Surgery at Fudan University Shanghai Cancer Center, where he holds the position of Academic Director of Head and Neck Surgery at the Minhang Campus. He holds a Doctorate in Oncology.

With over 20 years of experience in oncological surgery, Dr. SHI Rongliang's primary focus is the clinical practice and research of thyroid cancer and head and neck tumors. He personally performs over 1,000 various thyroid cancer surgeries annually, with his team handling nearly 10,000 cases, including over a hundred robotic surgeries. He specializes in clinical and fundamental research on medullary thyroid carcinoma. As the first or corresponding author, he has consecutively published articles in top-tier international journals such as Nature Communications, Cell Discovery, and Thyroid. He serves as a Corresponding Editorial Board Member for World Science of Academy, a peer-review expert for International Journal of Oncology and the Chinese Journal of Cancer. He has led one research project funded by the China Thyroid Cancer Foundation and participated in several projects supported by the National Natural Science Foundation of China. He has co-authored three medical monographs and secured a research grant from the Shanghai Municipal Commission of Health and Family Planning. Dr. SHI was also a recipient of the National Scholarship for Doctoral Candidates at Fudan University.

Dr. SHI Rongliang holds memberships in several professional committees, including serving as a Committee Member of the Medical Robot Development Promotion Branch of the China Medical Education Association, a Youth Editorial Board Member of the Chinese Journal of General Surgery, a Committee Member of the Endoscopic Thyroid Surgery Group of the Shanghai Association of Integrative Medicine, and a Youth Committee Member of the Shanghai Association of Integrative Medicine.

Expertise
Specializes in minimally invasive endoscopic thyroid cancer surgery with small neck incisions, scarless total endoscopic cosmetic thyroid surgery (transoral, transthoracic, infraclavicular, and transaxillary approaches), reoperation for recurrent thyroid malignancies, resection and reconstruction for locally advanced thyroid cancer invading the trachea and esophagus, and mediastinal lymph node dissection for thyroid malignancies (via open thoracic or minimally invasive endoscopic approaches) in collaboration with thoracic surgery, as well as the diagnosis and treatment of other head and neck diseases.

Profile
Dr. ZHANG Deguang is a specially appointed expert in the Department of General Surgery at Jiahui Hospital. He also serves as Assistant Director of the Head and Neck Surgery Department at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Director of the Head and Neck Surgery Department at the Qiantang Branch, Chief Physician, and Postgraduate Supervisor. Dr. ZHANG graduated from Zhejiang University with a Doctor of Medicine degree. He pioneered the application of endoscopic techniques for mediastinal lymph node dissection in thyroid cancer with mediastinal metastasis, avoiding the need for open thoracic surgery and significantly reducing patient trauma. He established a system for minimally invasive endoscopic-assisted lateral neck dissection for thyroid malignancies and has personally performed over 2,000 such procedures. He led the development of the Chinese Expert Consensus on Endoscopic-Assisted Lateral Neck Dissection for Thyroid Cancer via Anterior Cervical Small Incision (2023 Edition). Dr. ZHANG pioneered a modified infraclavicular approach for endoscopic thyroid surgery in China, with over 2,000 personal cases, and has widely promoted this technique nationally. He is proficient in other scarless endoscopic thyroid surgeries, including transoral vestibular and transaxillary total endoscopic thyroid cancer surgeries. He is also skilled in minimally invasive cosmetic endoscopic surgeries for submandibular glands, parotid glands, and branchial cleft cysts. His expertise extends to complex reoperations for thyroid cancer, including resection of recurrent or residual tumors; surgeries for locally advanced thyroid cancer, including function-preserving procedures for tumors invading the trachea, esophagus, larynx, and other organs; comprehensive treatment for poorly differentiated and anaplastic thyroid cancer; and surgical and comprehensive treatment for medullary thyroid carcinoma.

Professional Affiliations
•Standing Committee Member, Thyroid Cancer Professional Committee, Chinese Anti-Cancer Association
•Committee Member, Head and Neck Oncology Professional Committee, Chinese Anti-Cancer Association
•Committee Member, Minimally Invasive Thyroid Surgery Branch, Chinese Anti-Cancer Association
•Committee Member, Thyroid Disease Professional Committee, Chinese Research Hospital Association
•Standing Committee Member, Head and Neck Tumor Professional Committee, Chinese Medical Education Association
•Committee Member, Thyroid Disease Professional Committee, China International Exchange and Promotive Association for Medical and Health Care
•Committee Member, Thyroid Surgery Group, Thyroid Disease Professional Committee, Chinese Research Hospital Association
•Committee Member, Intelligent Robotics Group, Thyroid Disease Professional Committee, Chinese Research Hospital Association
•Committee Member, International Exchange Committee, Thyroid Disease Professional Committee, Chinese Research Hospital Association
•Committee Member, Thyroid Cancer Professional Committee, Chinese Society of Clinical Oncology (CSCO)
•Committee Member, Thyroid Cancer Professional Committee, Zhejiang Anti-Cancer Association
•Committee Member, Minimally Invasive Surgery Branch, Zhejiang Medical Association
•Corresponding Editorial Board Member, Chinese Journal of Surgery
•Editorial Board Member, Laparoscopic, Endoscopic and Robotic Surgery

Dr. CHEN Xi is a multi-site practicing physician at Shanghai Jiahui International Hospital and currently serves as Chief Physician and Master's Supervisor in the Department of Endocrine Surgery at Ruijin Hospital. Dr. CHEN specializes in surgical and medical treatments for endocrine disorders, including thyroid, parathyroid, and pancreatic endocrine tumors.

Professional Roles

1 Member of the Thyroid and Metabolic Surgery Group, Surgery Branch, Chinese Medical Association
2 Committee Member of the Thyroid Surgery Committee, Chinese Association of Surgeons
3 Standing Committee Member and Deputy Leader/Member of multiple subcommittees at the Chinese Research Hospital Association (CRHA) Thyroid Disease Committee
4 Standing Committee Member and Secretary-General of the CRHA Parathyroid and Bone Metabolism Diseases Committee
5 Member of the Surgical Medical Equipment Committee (Thyroid Surgery Group), China Association of Medical Equipment
6 Standing Committee Member of the Clinical Practical Technologies Branch, China International Exchange and Promotive Association for Medical and Health Care
7 Editorial Board Member and Peer Reviewer for core journals such as Chinese Journal of Surgery.

Specialty: Surgical treatment of thyroid diseases
Introduction: Deputy Director of thyroid vascular Surgery, Ruijin Hospital. He graduated from the Department of Clinical Medicine, Shanghai Second Medical University in 1990 and received his master's degree in surgery in 1997.

He has worked in the general surgery department of Ruijin Hospital for 30 years, and is a versatile player who has played an outstanding role in various aspects of medicine, teaching and research. He is good at the surgical treatment of thyroid diseases, and his earnest and practical working attitude and rigorous surgical style have won praise and affirmation from countless patients. In particular, his research on the surgical treatment of thyroid tumors is quite deep, and he has published nearly ten papers in core journals and two SCI articles. He has won the "Most Beautiful Doctor Nomination Award" of Ruijin Hospital, " Service Model with Patient Satisfaction", "Loving staff", "Excellent Communist Party Member" and other titles.